Results 1-38 of 38 (Search time: 0.179 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12021Spectrum of cancer patients receiving renal biopsyChang F.-C.; WEI-WU CHEN ; Huang T.T.-M.; Lin W.-C.; Liu J.-S.; Chiang W.-C.; Chen Y.-M.; Hsu C.; Yeh K.-H.; Chu T.-S.Journal of the Formosan Medical Association0
22021The treatment landscape of advanced angiosarcoma in Asia�XA multi-national collaboration from the Asian Sarcoma ConsortiumWEI-WU CHEN ; Pang A.; Puhaindran M.E.; Maw M.M.; Loong H.H.; Sriuranpong V.; Chang C.-C.; Mingmalairak S.; Hirose T.; Endo M.; Kawai A.; Farid M.; Tan S.H.; Goh W.L.; Quek R.; Chan J.C.H.; Leung A.K.C.; Ngan R.K.C.Cancer Science14
32021B cells and cancer: To B or not to B?Fridman W.H.; Petitprez F.; Meylan M.; WEI-WU CHEN ; Sun C.-M.; Roumenina L.T.; Saut?s-Fridman C.Journal of Experimental Medicine1111
42021Systemic therapies in advanced epithelioid haemangioendothelioma: A retrospective international case series from the World Sarcoma Network and a review of literatureFrezza A.M.; Ravi V.; Lo Vullo S.; Vincenzi B.; Tolomeo F.; WEI-WU CHEN ; Teterycz P.; Baldi G.G.; Italiano A.; Penel N.; Brunello A.; Duffaud F.; Hindi N.; Iwata S.; Smrke A.; Fedenko A.; Gelderblom H.; Van Der Graaf W.; Vozy A.; Connolly E.; Grassi M.; Benjamin R.S.; Broto J.-M.; Grignani G.; Jones R.L.; Kawai A.; Tysarowski A.; Mariani L.; Casali P.G.; Stacchiotti S.Cancer Medicine3
52020The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcomaHeng M.; Gupta A.; Chung P.W.; Healey J.H.; Vaynrub M.; Rose P.S.; Houdek M.T.; Lin P.P.; Bishop A.J.; Hornicek F.J.; Chen Y.-L.; Lozano-Calderon S.; Holt G.E.; Han I.; Biau D.; Niu X.; Bernthal N.M.; Ferguson P.C.; Wunder J.S.; Ueda T.; Kakunaga S.; Kawai A.; Sugiura H.; Kidani T.; Kunisasa T.; Ozaki T.; Ae K.; Nagano A.; Ohno T.; Hiraoka K.; Yamamoto N.; Tsuchiya H.; Matsumoto Y.; Yanagawa T.; Nakayama R.; Morioka H.; Kubo T.; Simose S.; Yamagami Y.; Yamamoto T.; Kawasaki M.; Torigoe T.; Yazawa Y.; Akiyama T.; Gokita T.; Manabe J.; Kaya M.; Emori M.; Nakamura T.; Matsumine A.; Sugihara S.; Yokouchi M.; Komiya S.; Suehara Y.; Takagi T.; Kawamoto T.; Wasa J.; Yonemoto T.; Ishii T.; Baba I.; Hoshi M.; Hamada K.; Naka N.; Sotobori T.; Araki N.; Okuma T.; Goto T.; Kobayashi H.; Kawano H.; Hosaka M.; Futani H.; Hiraga H.; Nishida Y.; Griffin A.; Razak A.R.A.; Shultz D.B.; Catton C.; Robinson S.; Patel S.R.; Lewis V.O.; Guadagnolo B.A.; DeLaney T.; Wang H.; Raskin K.; Callan A.K.; Henshaw R.; Isler M.; Mottard S.; Chen W.-M.; Traub F.; WEI-WU CHEN ; Turcotte R.E.; Davidson D.; Tunn P.-U.; Loong H.; Ghert M.; Werier J.; Clarkson P.; Abraham J.A.; Japanese Musculoskeletal Oncology Group (JMOG), Soft Tissue Osteosarcoma International Collaborative (STOIC)European Journal of Cancer1515
62020Tertiary Lymphoid Structures and B cells: Clinical impact and therapeutic modulation in cancerSaut?s-Fridman C.; Verneau J.; Sun C.-M.; Moreira M.; WEI-WU CHEN ; Meylan M.; Petitprez F.; Fridman W.H.Seminars in Immunology66
72020A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumorsLee J.-H.; WEI-WU CHEN ; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C.Investigational New Drugs2521
82020B cells are associated with survival and immunotherapy response in sarcomaPetitprez F.; de Reyni?s A.; Keung E.Z.; WEI-WU CHEN ; Sun C.-M.; Calderaro J.; Jeng Y.-M.; Hsiao L.-P.; Lacroix L.; Bougo?in A.; Moreira M.; Lacroix G.; Natario I.; Adam J.; Lucchesi C.; Laizet Y.; Toulmonde M.; Burgess M.A.; Bolejack V.; Reinke D.; Wani K.M.; Wang W.-L.; Lazar A.J.; Roland C.L.; Wargo J.A.; Italiano A.; Saut?s-Fridman C.; Tawbi H.A.; Fridman W.H.Nature411396
92020Optimal clinical management and the molecular biology of angiosarcomasWEI-WU CHEN ; Burns J.; Jones R.L.; Huang P.H.Cancers6
102020Genomic-guided precision therapy for soft tissue sarcomaChen H.-W.; WEI-WU CHEN ESMO Open21
112020Tumor-infiltrating lymphocyte abundance and programmed death-ligand 1 expression in metaplastic breast carcinoma: implications for distinct immune microenvironments in different metaplastic componentsLien H.-C.; Lee Y.-H.; Chen I.-C.; Lin C.-H.; WEI-WU CHEN ; Lu Y.-T.; Lu Y.-S.Virchows Archiv4
122020Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket studyGounder M.; Sch?ffski P.; Jones R.L.; Agulnik M.; Cote G.M.; Villalobos V.M.; Attia S.; Chugh R.; WEI-WU CHEN ; Jahan T.; Loggers E.T.; Gupta A.; Italiano A.; Demetri G.D.; Ratan R.; Davis L.E.; Mir O.; Dileo P.; Van Tine B.A.; Pressey J.G.; Lingaraj T.; Rajarethinam A.; Sierra L.; Agarwal S.; Stacchiotti S.The Lancet Oncology4639
132020Systemic treatment of breast cancer with leptomeningeal metastases using bevacizumab, etoposide and cisplatin (BEEP regimen) significantly improves overall survivalWEI-WU CHEN ; Jan I.-S.; Chang D.-Y.; Lin C.-H.; Chen I.-C.; Chen H.-M.; Cheng A.-L.; Lu Y.-S.Journal of Neuro-Oncology76
142020When molecular-targeted agents meet immunotherapy: The opportunities for soft tissue sarcomaWainsztein V.E.; WEI-WU CHEN Journal of Immunotherapy and Precision Oncology0
152019Prognostic factors and treatment outcomes of malignant pleural mesothelioma in Eastern Asian patients �V A Taiwanese studyWu T.-H.; Lee L.J.-H.; Yuan C.-T.; WEI-WU CHEN ; Yang J.C.-H.Journal of the Formosan Medical Association54
162019Clinicopathologic Characterization of GREB1 -rearranged Uterine Sarcomas With Variable Sex-Cord DifferentiationLee C.-H.; Kao Y.-C.; Lee W.-R.; Hsiao Y.-W.; Lu T.-P.; Chu C.-Y.; Lin Y.-J.; Huang H.-Y.; Hsieh T.-H.; Liu Y.-R.; Liang C.-W.; WEI-WU CHEN ; Yip S.; Lum A.; Kuo K.-T.; Jeng Y.-M.; Yu S.-C.; Chung Y.-C.; Lee J.-C.American Journal of Surgical Pathology1616
172019Primary cardiac sarcomas: A multi-national retrospective review ournal AArticleWEI-WU CHEN ; Loong H.H.; Srikanthan A.; Zer A.; Barua R.; Butany J.; Cusimano R.J.; Liang Y.-C.; Chang C.-H.; Iakobishvili Z.; Razak A.R.A.; Lewin J.Cancer Medicine1411
182019Primary Ewing Family of Tumor Arising in the Ovary: A Case ReportLi Y.-P.; Chang K.; WEI-WU CHEN ; Lee S.-P.; Chen C.-A.; Cheng W.-F.International Journal of Gynecological Pathology41
192018Managing the adverse effects related to immune checkpoint inhibitorsKuo H.-H.; WEI-WU CHEN Journal of Nursing20
202018A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancerWEI-WU CHEN ; Yeh D.-C.; Chao T.-Y.; Lin C.-H.; Chow L.W.-C.; Chang D.-Y.; Hsieh Y.-Y.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.; Taiwan Breast Cancer ConsortiumJapanese Journal of Clinical Oncology33
212018Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancerPezo R.C.; WEI-WU CHEN ; Berman H.K.; Mulligan A.M.; Razak A.A.; Siu L.L.; Cescon D.W.; Amir E.; Elser C.; Warr D.G.; Sridhar S.S.; Yu C.; Wang L.; Stockley T.L.; Kamel-Reid S.; Bedard P.L.Breast Cancer Research and Treatment1414
222018Imaging biomarkers from multiparametric magnetic resonance imaging are associated with survival outcomes in patients with brain metastases from breast cancerChen B.-B.; Lu Y.-S.; Yu C.-W.; Lin C.-H.; WEI-WU CHEN ; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.European Radiology77
232018Next frontiers in systemic therapy for soft tissue sarcomaYen C.-C.; WEI-WU CHEN Chinese Clinical Oncology55
242017Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review ournal AArticlePrawira A.; Oosting S.F.; WEI-WU CHEN ; Delos Santos K.A.; Saluja R.; Wang L.; Siu L.L.; Chan K.K.W.; Hansen A.R.British Journal of Cancer3433
252016Should pertuzumab be used as part of neoadjuvant treatment prior to the release of the APHINITY trial results?WEI-WU CHEN ; Lin C.-H.; Huang C.-S.Translational Cancer Research1
262016New hope for HER2-positive metastatic breast cancer treatment: Trastuzumab emtansine (T-DM1) from the perspective of nursing careKuo H.-H.; WEI-WU CHEN Journal of Nursing20
272016A pilot study to determine the timing and effect of bevacizumab on vascular normalization of metastatic brain tumors in breast cancerChen B.-B.; Lu Y.-S.; Lin C.-H.; WEI-WU CHEN ; Wu P.-F.; Hsu C.-Y.; Yu C.-W.; Wei S.-Y.; Cheng A.-L.; Shih T.T.-F.BMC Cancer1412
28201618F-NaF PET/CT images of cardiac metastasis from osteosarcomaChou Y.-H.; Ko K.-Y.; Cheng M.-F.; WEI-WU CHEN ; Yen R.-F.Clinical Nuclear Medicine1516
292016Tailor the adjuvant hormonal manipulation for premenopausal breast cancer patientsWEI-WU CHEN ; Lin C.-H.; Lu Y.-S.Translational Cancer Research0
302015A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosisWu P.-F.; Lin C.-H.; Kuo C.-H.; WEI-WU CHEN ; Yeh D.-C.; Liao H.-W.; Huang S.-M.; Cheng A.-L.; Lu Y.-S.BMC Cancer3329
312015Bevacizumab preconditioning followed by etoposide and cisplatin is highly effective in treating brain metastases of breast cancer progressing from whole-brain radiotherapyLu Y.-S.; WEI-WU CHEN ; Lin C.-H.; Yeh D.-C.; Tseng L.-M.; Wu P.-F.; Rau K.-M.; Chen B.-B.; Chao T.-C.; Huang S.-M.; Huang C.-S.; Shih T.T.-F.; Cheng A.-L.; Taiwan Breast Cancer ConsortiumClinical Cancer Research5044
322015TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 AssaysLin C.-H.; Chen I.-C.; Huang C.-S.; Hu F.-C.; Kuo W.-H.; Kuo K.-T.; Wang C.-C.; Wu P.-F.; Chang D.-Y.; Wang M.-Y.; Chang C.-H.; WEI-WU CHEN ; Lu Y.-S.; Cheng A.-L.Scientific Reports78
332015High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian countryLin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; WEI-WU CHEN ; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L.PLoS ONE95
342014No increased venous thromboembolism risk in Asian breast cancer patients receiving adjuvant tamoxifenWEI-WU CHEN ; Chen H.-M.; Lin C.-H.; Huang C.-S.; Cheng A.-L.; Lai M.-S.; Lu Y.-S.Breast Cancer Research and Treatment75
352013Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapyWEI-WU CHEN ; Lin C.-C.; Huang T.-C.; Cheng A.-L.; Yeh K.-H.; Hsu C.-H.Anticancer Research8
362013Personalized medicine for metastatic breast cancerWEI-WU CHEN ; Bedard P.L.Current Opinion in Oncology76
372013The first two lines of chemotherapy for anthracycline-naive metastatic breast cancer: A comparative study of the efficacy of anthracyclines and non-anthracyclinesWEI-WU CHEN ; Chang D.-Y.; Huang S.-M.; Lin C.-H.; Hsu C.; Lin M.-H.; Huang C.-S.; Lu Y.-S.; Cheng A.-L.Breast45
382012The impact of diabetes mellitus on prognosis of early breast cancer in AsiaWEI-WU CHEN ; Shao Y.-Y.; Shau W.-Y.; Lin Z.-Z.; Lu Y.-S.; Chen H.-M.; Kuo R.N.C.; Cheng A.-L.; Lai M.-S.Oncologist3634